IDEXX Laboratories Inc (IDXX)
Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell
$495.41
Buy
$540.00
$3.58 (+0.69%)
IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
Prices updated at 20 May 2025, 00:34 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Lawrence D. Kingsley
CEO
Mr. Jonathan J. Mazelsky
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
11,000
Head office
One IDEXX Drive
Westbrook
United States
04092
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Brian P. Mckeon Executive Vice President and Special Advisor | 0.69m | - | - | 3.89m | - |
Mr. Bruce L. Claflin Independent Director | 0.11m | - | - | 0.36m | - |
Mr. Daniel M. Junius Independent Director | 0.12m | - | - | 0.37m | - |
Ms. M. Anne Szostak Independent Director | 0.12m | - | - | 0.37m | - |
Mr. Lawrence D. Kingsley Non-Executive Chairman of the Board | 0.17m | - | - | 0.50m | - |
Dr. Sophie V. Vandebroek, PhD Independent Director | 0.09m | - | - | 0.34m | - |
Mr. Stuart M. Essig, PhD Independent Director | 0.11m | - | - | 0.35m | - |
Ms. Irene Chang Britt Independent Director | 0.11m | - | - | 0.36m | - |
Mr. George J. Fennell Executive Vice President, Global CAG Commercial | - | - | - | - | - |
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer | 1.12m | - | - | 13.01m | - |
Dr. Martin Alexander Smith, PhD Executive Vice President, Global Operations and Research and Development | 0.58m | - | - | 3.72m | - |
Ms. Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary | - | - | - | - | - |
Mr. Sam A. Samad Independent Director | 0.10m | - | - | 0.35m | - |
Mr. Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology | 0.58m | - | - | 3.73m | - |
Dr. Nimrata Khatra Hunt, PhD Executive Vice President, Global Strategy and Commercial | 0.58m | - | - | 3.73m | - |
Mr. Michael P. Johnson Senior Vice President and Chief Human Resources Officer | - | - | - | - | - |
Dr. Michael G. Erickson, PhD Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine | - | - | - | - | - |
Mr. Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience | - | - | - | - | - |
Mr. Andrew Emerson Executive Vice President, Chief Financial Officer and Treasurer | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 9,855,937 | 0.07483 | 146427 | 1.508078 | 30 Apr 2025 | 12.26 |
| Vanguard Group Inc. ( Junked) | 9,703,237 | - | 9703237 | - | 30 Apr 2025 | 11.85 |
| BlackRock Inc | 8,703,074 | 0.07677 | 230512 | 2.720688 | 30 Apr 2025 | 10.82 |
| State Street Corp | 3,637,560 | 0.05933 | 24200 | 0.669737 | 30 Apr 2025 | 4.52 |
| BlackRock Fund Advisors | 3,586,704 | 13.39899 | -130297 | - | 30 Apr 2025 | 4.46 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 27 Nov 2024 | - | Dr. Sophie V. Vandebroek, PhD | 420.44 | 144,630 | 905 | - | - |
| 27 Nov 2024 | - | Dr. Sophie V. Vandebroek, PhD | - | - | 1,249 | - | - |
| 06 Sep 2024 | - | Mr. Jonathan W. Ayers | - | - | 35,651 | - | - |
| 06 Sep 2024 | - | Mr. Jonathan W. Ayers | - | - | 122,605 | - | - |
| 06 Sep 2024 | - | Mr. Jonathan W. Ayers | - | - | 419,574 | - | - |
| 06 Sep 2024 | - | Mr. Jonathan W. Ayers | - | - | - | - | - |
| 05 Sep 2024 | - | Ms. M. Anne Szostak | - | - | 500 | - | - |
| 06 Sep 2024 | - | Ms. M. Anne Szostak | 469.37 | 234,686 | - | - | - |
| 05 Sep 2024 | - | Ms. M. Anne Szostak | - | - | 6,061 | - | - |
| 01 Sep 2024 | - | Dr. Martin Alexander Smith, PhD | - | - | 18 | - | - |
| 01 Sep 2024 | - | Dr. Martin Alexander Smith, PhD | 481.33 | 2,407 | 510 | - | - |
| 01 Sep 2024 | - | Dr. Martin Alexander Smith, PhD | - | - | 515 | - | - |
| 01 Sep 2024 | - | Mr. Michael Schreck | - | - | 961 | - | - |
| 01 Sep 2024 | - | Mr. Michael Schreck | - | - | - | - | - |
| 01 Sep 2024 | - | Mr. Michael Schreck | 481.33 | 23,104 | 913 | - | - |
| 05 Aug 2024 | - | Mr. Brian P. Mckeon | - | - | - | - | - |
| 05 Aug 2024 | - | Mr. Brian P. Mckeon | 455.08 | 53,244 | 30,932 | - | - |
| 05 Aug 2024 | - | Mr. Brian P. Mckeon | - | - | 31,049 | - | - |
| 05 Aug 2024 | - | Mr. Jonathan J. Mazelsky | - | - | 81,903 | - | - |
| 05 Aug 2024 | - | Mr. Jonathan J. Mazelsky | - | - | - | - | - |
Please note that past performance is not a reliable indicator of future returns.
